Shamburg News · 8-K filed Nov 18, 2026, 8:30 AM EST
Tempus AI Amends AstraZeneca Master Services Agreement, Sets $200 Million Commitment
TEM · Tempus AI, Inc.
- Material agreement
- Materiality: high
On November 16, 2026, Tempus AI, Inc. and AstraZeneca AB entered into a Fifth Amendment to their Master Services Agreement, effective January 1, 2027. The amendment establishes a five-year financial commitment period and extends the term through December 31, 2031. AstraZeneca committed to an aggregate of $200 million in fees during the renewal term, with a minimum of $32 million per calendar year.
Source: SEC EDGAR, Form 8-K, Items 1.01, 9.01, accession 0001193125-26-466240.
Written from the filing by Shamburg Markets. Figures are as reported by the company.